Predictive Oncology Inc. - Common Stock (POAI)

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Predictive Oncology shares are trading higher on Tuesday after the company announced it developed predictive models to target various cancer types.

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Predictive Oncology just reported results for the second quarter of 2024.

Predictive Oncology’s AI-driven platform demonstrated predictive utility in oncology, thereby providing credibility to POAI stock.

Predictive Oncology stock is trading higher on Tuesday after the company reported positive results from utilizing artificial intelligence for drug repurposing.

Predictive Oncology shares are blasting higher Thursday after the company announced it is expanding its AI and machine learning driven drug discovery platform to pursue discovery of novel biomarkers. Here's a look at what's going on:

A good rating for growth in the Portfolio Grader doesn't tell the full picture. These are all growth stocks to avoid now.

Predictive Oncology shares are trading higher by 46.6% during Tuesday's session. The company announced positive results from a retrospective study conducted with UPMC Magee-Womens Hospital.